Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Cancer Research|2016Cited by 115
Abstract 207: Dual targeting of DLL4 and VEGF signaling by a novel bispecific antibody inhibits tumor growth and reduces cancer stem cell frequencyWan-Ching Yen, Timothy Hoey, Cécile Chartier et al.|Cancer Research|2014Cited by 1
Abstract 218: R-Spondin (RSPO) signaling drives the growth of multiple human tumor types.Austin Gurney, Timothy Hoey, Cécile Chartier et al.|Cancer Research|2013Cited by 0
Data from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Unknown|2023Cited by 0
Data from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Unknown|2023Cited by 0